Literature DB >> 23169527

The β-catenin destruction complex.

Jennifer L Stamos1, William I Weis.   

Abstract

The Wnt/β-catenin pathway is highly regulated to insure the correct temporal and spatial activation of its target genes. In the absence of a Wnt stimulus, the transcriptional coactivator β-catenin is degraded by a multiprotein "destruction complex" that includes the tumor suppressors Axin and adenomatous polyposis coli (APC), the Ser/Thr kinases GSK-3 and CK1, protein phosphatase 2A (PP2A), and the E3-ubiquitin ligase β-TrCP. The complex generates a β-TrCP recognition site by phosphorylation of a conserved Ser/Thr-rich sequence near the β-catenin amino terminus, a process that requires scaffolding of the kinases and β-catenin by Axin. Ubiquitinated β-catenin is degraded by the proteasome. The molecular mechanisms that underlie several aspects of destruction complex function are poorly understood, particularly the role of APC. Here we review the molecular mechanisms of destruction complex function and discuss several potential roles of APC in β-catenin destruction.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23169527      PMCID: PMC3579403          DOI: 10.1101/cshperspect.a007898

Source DB:  PubMed          Journal:  Cold Spring Harb Perspect Biol        ISSN: 1943-0264            Impact factor:   10.005


  139 in total

1.  Mutations in AXIN2 cause colorectal cancer with defective mismatch repair by activating beta-catenin/TCF signalling.

Authors:  W Liu; X Dong; M Mai; R S Seelan; K Taniguchi; K K Krishnadath; K C Halling; J M Cunningham; L A Boardman; C Qian; E Christensen; S S Schmidt; P C Roche; D I Smith; S N Thibodeau
Journal:  Nat Genet       Date:  2000-10       Impact factor: 38.330

2.  AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1.

Authors:  S Satoh; Y Daigo; Y Furukawa; T Kato; N Miwa; T Nishiwaki; T Kawasoe; H Ishiguro; M Fujita; T Tokino; Y Sasaki; S Imaoka; M Murata; T Shimano; Y Yamaoka; Y Nakamura
Journal:  Nat Genet       Date:  2000-03       Impact factor: 38.330

3.  A new Drosophila APC homologue associated with adhesive zones of epithelial cells.

Authors:  X Yu; L Waltzer; M Bienz
Journal:  Nat Cell Biol       Date:  1999-07       Impact factor: 28.824

4.  The APC tumour suppressor has a nuclear export function.

Authors:  R Rosin-Arbesfeld; F Townsley; M Bienz
Journal:  Nature       Date:  2000-08-31       Impact factor: 49.962

5.  Crystal structure of the amino-terminal coiled-coil domain of the APC tumor suppressor.

Authors:  C L Day; T Alber
Journal:  J Mol Biol       Date:  2000-08-04       Impact factor: 5.469

6.  Structural basis of the Axin-adenomatous polyposis coli interaction.

Authors:  K E Spink; P Polakis; W I Weis
Journal:  EMBO J       Date:  2000-05-15       Impact factor: 11.598

7.  Control of beta-catenin stability: reconstitution of the cytoplasmic steps of the wnt pathway in Xenopus egg extracts.

Authors:  A Salic; E Lee; L Mayer; M W Kirschner
Journal:  Mol Cell       Date:  2000-03       Impact factor: 17.970

8.  Asef, a link between the tumor suppressor APC and G-protein signaling.

Authors:  Y Kawasaki; T Senda; T Ishidate; R Koyama; T Morishita; Y Iwayama; O Higuchi; T Akiyama
Journal:  Science       Date:  2000-08-18       Impact factor: 47.728

9.  L-leucine availability regulates phosphatidylinositol 3-kinase, p70 S6 kinase and glycogen synthase kinase-3 activity in L6 muscle cells: evidence for the involvement of the mammalian target of rapamycin (mTOR) pathway in the L-leucine-induced up-regulation of system A amino acid transport.

Authors:  K Peyrollier; E Hajduch; A S Blair; R Hyde; H S Hundal
Journal:  Biochem J       Date:  2000-09-01       Impact factor: 3.857

10.  GSK-3beta-dependent phosphorylation of adenomatous polyposis coli gene product can be modulated by beta-catenin and protein phosphatase 2A complexed with Axin.

Authors:  S Ikeda; M Kishida; Y Matsuura; H Usui; A Kikuchi
Journal:  Oncogene       Date:  2000-01-27       Impact factor: 9.867

View more
  377 in total

Review 1.  Phosphorylation and isoform use in p120-catenin during development and tumorigenesis.

Authors:  Ji Yeon Hong; Il-Hoan Oh; Pierre D McCrea
Journal:  Biochim Biophys Acta       Date:  2015-10-23

2.  Wnt signaling and astrocytic brain tumors.

Authors:  Nives Pećina-Šlaus; Anja Kafka
Journal:  CNS Oncol       Date:  2015

3.  The Scaffold Protein Axin Promotes Signaling Specificity within the Wnt Pathway by Suppressing Competing Kinase Reactions.

Authors:  Maire Gavagan; Erin Fagnan; Elizabeth B Speltz; Jesse G Zalatan
Journal:  Cell Syst       Date:  2020-06-17       Impact factor: 10.304

4.  High-resolution chromatin immunoprecipitation (ChIP) sequencing reveals novel binding targets and prognostic role for SOX11 in mantle cell lymphoma.

Authors:  P-Y Kuo; V V Leshchenko; M J Fazzari; D Perumal; T Gellen; T He; J Iqbal; S Baumgartner-Wennerholm; L Nygren; F Zhang; W Zhang; K S Suh; A Goy; D T Yang; W-C Chan; B S Kahl; A K Verma; R D Gascoyne; E Kimby; B Sander; B H Ye; A M Melnick; S Parekh
Journal:  Oncogene       Date:  2014-03-31       Impact factor: 9.867

Review 5.  A Comprehensive Overview of Skeletal Phenotypes Associated with Alterations in Wnt/β-catenin Signaling in Humans and Mice.

Authors:  Kevin A Maupin; Casey J Droscha; Bart O Williams
Journal:  Bone Res       Date:  2013-03-29       Impact factor: 13.567

Review 6.  Wnt signaling in cardiovascular disease: opportunities and challenges.

Authors:  Austin Gay; Dwight A Towler
Journal:  Curr Opin Lipidol       Date:  2017-10       Impact factor: 4.776

7.  Limited dishevelled/Axin oligomerization determines efficiency of Wnt/β-catenin signal transduction.

Authors:  Wei Kan; Michael D Enos; Elgin Korkmazhan; Stefan Muennich; Dong-Hua Chen; Melissa V Gammons; Mansi Vasishtha; Mariann Bienz; Alexander R Dunn; Georgios Skiniotis; William I Weis
Journal:  Elife       Date:  2020-04-16       Impact factor: 8.140

8.  Loss of Nmp4 optimizes osteogenic metabolism and secretion to enhance bone quality.

Authors:  Yu Shao; Emily Wichern; Paul J Childress; Michele Adaway; Jagannath Misra; Angela Klunk; David B Burr; Ronald C Wek; Amber L Mosley; Yunlong Liu; Alexander G Robling; Nickolay Brustovetsky; James Hamilton; Kylie Jacobs; Deepak Vashishth; Keith R Stayrook; Matthew R Allen; Joseph M Wallace; Joseph P Bidwell
Journal:  Am J Physiol Endocrinol Metab       Date:  2019-01-15       Impact factor: 4.310

Review 9.  Immunobiology of hepatocarcinogenesis: Ways to go or almost there?

Authors:  Pavan Patel; Steven E Schutzer; Nikolaos Pyrsopoulos
Journal:  World J Gastrointest Pathophysiol       Date:  2016-08-15

10.  Crumbs promotes expanded recognition and degradation by the SCF(Slimb/β-TrCP) ubiquitin ligase.

Authors:  Paulo Ribeiro; Maxine Holder; David Frith; Ambrosius P Snijders; Nicolas Tapon
Journal:  Proc Natl Acad Sci U S A       Date:  2014-04-28       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.